1. Home
  2. BGS vs MGNX Comparison

BGS vs MGNX Comparison

Compare BGS & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BGS

B&G Foods Inc.

HOLD

Current Price

$2.93

Market Cap

297.1M

ML Signal

HOLD

Logo MacroGenics Inc.

MGNX

MacroGenics Inc.

HOLD

Current Price

$4.12

Market Cap

280.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGS
MGNX
Founded
1996
2000
Country
United States
United States
Employees
86
N/A
Industry
Packaged Foods
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.1M
280.3M
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
BGS
MGNX
Price
$2.93
$4.12
Analyst Decision
Hold
Buy
Analyst Count
5
5
Target Price
$4.90
$5.00
AVG Volume (30 Days)
1.9M
396.8K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
14.34%
N/A
EPS Growth
83.02
N/A
EPS
N/A
N/A
Revenue
$1,828,687,000.00
$149,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.52
$3.19
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.87
$1.30
52 Week High
$6.38
$5.08

Technical Indicators

Market Signals
Indicator
BGS
MGNX
Relative Strength Index (RSI) 26.91 50.96
Support Level N/A $3.85
Resistance Level $3.75 $4.50
Average True Range (ATR) 0.10 0.21
MACD -0.03 -0.00
Stochastic Oscillator 9.42 42.50

Price Performance

Historical Comparison
BGS
MGNX

About BGS B&G Foods Inc.

B&G Foods Inc manufactures, sells, and distributes a range of branded, shelf-stable, and frozen food and household products across the United States, Canada, and Puerto Rico. Its products include frozen and canned vegetables, canola and other cooking oils, vegetable shortening, cooking sprays, oatmeal and other hot cereals, fruit spreads, canned meats and beans, bagel chips, spices, seasonings, hot sauces, and wine vinegar. The company's main brands include Crisco, Clabber Girl, Bear Creek, Polaner, Underwood, B&G, Grandma's, New York Style, B&M, Baker's Joy, Regina, TrueNorth, Static Guard, SugarTwin and Brer Rabbit. It operates in four reportable segments: i) Specialty, the majoriy revenue generating segment, ii) Meals, iii) Frozen & Vegetables, iv) Spices & Flavor Solutions.

About MGNX MacroGenics Inc.

Macrogenics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-based therapeutics for the treatment of cancer. The company is currently developing therapeutics utilizing multiple modalities, including antibody-drug conjugates (ADCs) and multi-specific antibodies (which it refers to as DART and TRIDENT molecules). It is advancing three proprietary product candidates in clinical development: lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload, and MGC028, an ADC that targets ADAM9 and delivers a novel TOP1i-based linker-payload. Its segment is developing and commercializing monoclonal antibody-based therapeutics.

Share on Social Networks: